The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics
about
VPAC receptors: structure, molecular pharmacology and interaction with accessory proteinsTransmembrane signal transduction by peptide hormones via family B G protein-coupled receptorsMolecular basis of glucagon-like peptide 1 docking to its intact receptor studied with carboxyl-terminal photolabile probesTherapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagon-like peptide 1 and its receptor: a region critical for biological activity.Insights into the structure of class B GPCRs.Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.Vasoactive intestinal peptide signaling axis in human leukemia.Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometryCrucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.The VPAC1 receptor: structure and function of a class B GPCR prototype.Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritisPTHR1 mutations associated with Ollier disease result in receptor loss of function.Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.Conformational switches in the VPAC(1) receptor.Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles.
P2860
Q26827172-38E0A991-96E8-441B-9E04-79BC7F44E6DBQ28082755-1D8F1622-F331-4809-BAE6-F7BDDF2E97F0Q33553466-D34E5CF9-E619-4F27-B567-E5C575D1E703Q33652057-17C0D607-8921-4100-827D-4BFE8D5D973AQ34042564-B6E341EE-CAD4-457A-A412-3A2C8A0BB62DQ34393487-352D1C1D-AF56-485E-BC44-892FAA641C18Q34963202-722B76A8-10B2-4E32-AEA6-7C2B202828D2Q35103939-686AD907-5F45-4F8D-BE20-AC8362093CC1Q35295564-BCDB87B7-C0FE-463D-8221-D9E7829DAD6CQ35740179-44E0BDF8-3C96-406F-B0EB-89E114777821Q36394992-B7365382-3E76-4848-B9CA-6EAB2F98D525Q36403782-EE0169A9-137C-4C5B-999E-ECBB9D82BFC2Q36585653-41D4DB77-94A7-4969-A5D7-5BB00E66E1C6Q37294776-2F45C2DD-3230-435D-BB3D-95D9E3D81278Q37635253-65CE1E96-5D44-4762-8077-1A965C225DE2Q37909492-B46D7127-D2C7-4C62-9032-08304A374E48Q43230806-96505FE7-136A-4F1F-A58E-7C20F25C876E
P2860
The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The vasoactive intestinal pept ...... lecular modeling, and dynamics
@ast
The vasoactive intestinal pept ...... lecular modeling, and dynamics
@en
type
label
The vasoactive intestinal pept ...... lecular modeling, and dynamics
@ast
The vasoactive intestinal pept ...... lecular modeling, and dynamics
@en
prefLabel
The vasoactive intestinal pept ...... lecular modeling, and dynamics
@ast
The vasoactive intestinal pept ...... lecular modeling, and dynamics
@en
P2093
P2860
P356
P1476
The vasoactive intestinal pept ...... lecular modeling, and dynamics
@en
P2093
Emilie Ceraudo
Jean-Jacques Lacapère
Jean-Michel Neumann
Marc Laburthe
Yossan-Var Tan
P2860
P304
P356
10.1210/ME.2007-0361
P577
2007-09-20T00:00:00Z